| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 213.82B | 233.86B | 175.45B | 391.06B | 333.69B |
| Gross Profit | 41.60B | 69.05B | 27.59B | 173.07B | 141.15B |
| EBITDA | 52.15B | 66.17B | 56.15B | 191.24B | 144.68B |
| Net Income | 30.06B | 49.10B | 23.86B | 109.79B | 89.35B |
Balance Sheet | |||||
| Total Assets | 483.96B | 497.47B | 462.43B | 511.78B | 413.67B |
| Cash, Cash Equivalents and Short-Term Investments | 151.83B | 185.17B | 181.21B | 236.97B | 178.69B |
| Total Debt | 76.59B | 76.22B | 84.55B | 94.02B | 125.33B |
| Total Liabilities | 200.44B | 212.41B | 219.21B | 258.26B | 234.81B |
| Stockholders Equity | 232.36B | 234.67B | 196.12B | 200.38B | 133.09B |
Cash Flow | |||||
| Free Cash Flow | 21.51B | 43.31B | 7.29B | 186.31B | 161.40B |
| Operating Cash Flow | 45.88B | 69.31B | 22.61B | 196.80B | 170.95B |
| Investing Cash Flow | -27.23B | -26.97B | -18.35B | -32.98B | -8.54B |
| Financing Cash Flow | -49.41B | -40.62B | -60.02B | -115.38B | -34.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$84.78B | 7.76 | 48.55% | 9.80% | 11.50% | 17.54% | |
79 Outperform | HK$64.94B | 9.77 | 5.92% | 5.72% | 12.77% | -18.46% | |
74 Outperform | HK$20.63B | 8.82 | 5.04% | 4.97% | 10.96% | -4.09% | |
71 Outperform | HK$89.08B | 7.02 | 11.33% | 12.81% | -9.21% | -41.30% | |
65 Neutral | HK$244.79B | 6.39 | 13.13% | 12.48% | -6.12% | -35.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$121.10B | 10.71 | 9.13% | 4.76% | 2.50% | -2.32% |